Riskpilot← Back to searchSign inGet full accessMejvic Hälsa, IT och Utbildning AB
ABActiveOrg 5569643140Moje 509Medical specialists activities · NACE 8622Est. 20142 employees
Revenue 2024
SEK 1,5M
+30% vs 2023
EBITDA margin
51.8%
+54% vs 2023
Equity ratio
61.5%
Financial strength
Net profit 2024
SEK 351K
+42% vs 2023
| Revenue | SEK 1,5M | +30% |
| EBITDA | SEK 769K | +54% |
| Net profit | SEK 351K | +42% |
| Total assets | SEK 2,5M | +27% |
| Equity | SEK 1,5M | +21% |
| Employees | 2 | — |
Legal name
Mejvic Hälsa, IT och Utbildning AB
Org number
5569643140
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 mars 2014
Share capital
SEK 60 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva tjänster inom sjukvård, bioteknik och utbildning även IT och internetlösningar samt förvaltning av patent och därmed förenlig verksamhet.
Address
Moje 509
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 691 | 729 | 986 | 1 145 | 1 485 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 178 | 260 | 367 | 499 | 769 |
| Depreciation & amort. | −0 | −0 | −20 | −80 | −124 |
| EBIT | 178 | 260 | 347 | 419 | 645 |
| Net financials | −9 | −58 | −153 | −149 | −301 |
| Profit before tax | 169 | 231 | 268 | 341 | 487 |
| Tax | −39 | −57 | −76 | −94 | −136 |
| Net profit | 130 | 174 | 192 | 247 | 351 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 877 | 1 021 | 1 575 | 1 928 | 2 452 |
| Equity | 634 | 808 | 1 000 | 1 247 | 1 508 |
| Long-term debt | 0 | 0 | 265 | 230 | 341 |
| Short-term debt | 243 | 212 | 310 | 451 | 603 |
| Total debt | 243 | 212 | 575 | 681 | 944 |
EBITDA margin
51.8%
This company
15.8%
Market median
+228% vs market
20202024
Equity ratio
61.5%
This company
38.2%
Market median
+61% vs market
20202024
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
20202024
Net profit margin
23.6%
This company
8.1%
Market median
+191% vs market
20202024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20202024
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2023 | |
| Former (1) | ||
BM Audit | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mejvic Hälsa, IT och Utbildning AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mia Margareta Eva-Marie Funder | Audit | 0 companies |
| Bo Mikael Jannert | Audit | 0 companies |
| Mats Erik Joakim Gåfvels | Board of Directors | 0 companies |
| Magda Catharina Gåfvels | Board of Directors | 0 companies |
| Mats Erik Gåfvels | Chairman | 0 companies |